Andrew John Chin, DO
Internal Medicine · Cave Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 15
- Since medical school
- 10 years
- Midwestern University, Chicago College of Osteopathic Med, 2016
Offices
15 locations · Nextcare Arizona I Jv LLC · Circle the City · Vituity - Arizona Hospitalists PC · Banner-University Medical Group
Looking this up.
Hospitals listed: Honorhealth Deer Valley Medical Center · Honorhealth Sonoran Crossing Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chin’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Honorhealth Deer Valley Medical CenterPhoenix, AZAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of HonorHealth, which runs 7 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.309, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.325, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.187, Oct 2024 – Sep 2025
- Honorhealth Sonoran Crossing Medical CenterPhoenix, AZAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of HonorHealth, which runs 7 hospitalsPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Honorhealth Deer Valley Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.309 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.75) · 1,418 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.26 (0.95 to 1.56) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.08 (121.85 to 224.32) · 114 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.9 · 83 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.3 · 138 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 304 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 411 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.9 · 230 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,503 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 5,830 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,930 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (1.53 to 5.34) · 1,991 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.34 (0.83 to 3.85) · 813 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.77 to 3.56) · 1,849 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.51 (4.77 to 16.24) · 844 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.05 (3.56 to 10.54) · 821 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.23 (0.77 to 3.69) · 476 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.18 (0.48 to 1.88) · 4,914 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5 · 51 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.555 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.257 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 293 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 571 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.2 · 165 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7 · 347 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.1 · 444 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 769 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.5 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.6 · 134 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (9.4 to 15.6) · 1,077 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 477 cases | No different | Jan 2024 – Dec 2024 |
What patients said (558 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Honorhealth Sonoran Crossing Medical Center
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 6 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 283 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.5 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.1 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 896 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,592 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,609 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.84 (2.38 to 7.3) · 324 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.53 to 3.91) · 313 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.56 (0 to 18.29) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (0.76 to 9.26) · 114 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.21) · 92 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.42 (0 to 1.51) · 1,048 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 55 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.376 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.162 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 144 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 55.1 · 104 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.2 · 185 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.6) · 451 cases | No different | Jan 2024 – Dec 2024 |
What patients said (462 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 87% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 80% |
| Doctors "always" listened carefully | 83% |
| Doctors "always" treated them with courtesy and respect | 91% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 83% |
| Nurses "always" listened carefully | 85% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 68% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$34,455
Medicare paid this office $34,455 for 279 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 140 | $19,673 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,800 | $91 |
| Short return visit (20+ min) | 39 | $2,307 | $58 |
| New patient visit (30+ min) | 25 | $1,633 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,441 | $96 |
See all 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 140 | $19,673 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,800 | $91 |
| Short return visit (20+ min) | 39 | $2,307 | $58 |
| New patient visit (30+ min) | 25 | $1,633 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,441 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $903 | $60 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 16 | $649 | $41 |
Who their Medicare patients are
279 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 17% · Women 56% · Also on Medicaid 13% · Health risk score 1.55. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Coronary heart disease 45% · Chronic kidney disease 38% · Depression 33% · Diabetes 30% · Atrial fibrillation 26% · Heart failure 23% · COPD 20% · Cancer 17% · Dementia 15% · Stroke 13%.
The office billed $276,457, Medicare allowed $44,950 and paid $34,455; for 431 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 279 | 431 | 75 | 1.55 | $276,457 | $34,455 |
| 2023 | 311 | 626 | 74 | 1.41 | $192,061 | $36,496 |
| 2022 | 162 | 523 | 73 | 1.36 | $161,754 | $34,027 |
| 2021 | 39 | 141 | 72 | 1.34 | $21,020 | $6,141 |
| 2020 | 63 | 78 | 70 | 2.75 | $16,537 | $4,485 |
| 2019 | 24 | 27 | 67 | 1.20 | $7,369 | $2,393 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $8,439 | $134 |
| Short return visit (20+ min) | 105 | $6,948 | $60 |
| New patient visit (30+ min) | 55 | $3,926 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $3,676 | $92 |
| Long return visit (40+ min) | 13 | $2,968 | $129 |
| Return visit (30+ min) | 24 | $2,384 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,746 | $125 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,237 | $88 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 26 | $1,016 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $733 | $61 |
| Detection test by immunoassay with direct visual observation for influenza virus | 20 | $623 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 16 | $259 | $16 |
| Injection of drug or substance under skin or into muscle | 12 | $134 | $10 |
| Inhalation treatment for airway obstruction or sputum production | 16 | $103 | $6 |
| Automated urinalysis test | 22 | $53 | $2 |
2022: 12 services
| Return visit (30+ min) | 46 | $7,451 | $80 |
| Short return visit (20+ min) | 67 | $5,449 | $54 |
| Long return visit (40+ min) | 18 | $4,395 | $137 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $3,309 | $127 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 13 | $2,120 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,337 | $79 |
| New patient visit (45+ min) | 13 | $1,060 | $82 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 13 | $913 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $657 | $55 |
| Administration of influenza virus vaccine | 18 | $572 | $29 |
| New patient visit (30+ min) | 12 | $441 | $37 |
| Automated urinalysis test | 11 | $29 | $2 |
2021: 3 services
| New patient visit (45+ min) | 14 | $1,801 | $129 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 12 | $359 | $30 |
| Administration of influenza virus vaccine | 12 | $198 | $17 |
2020: 1 service
| Return visit (30+ min) | 16 | $913 | $48 |
Medicaid work
$70,462 in 2024
Medicaid paid $70,462 for 616 billed services this clinician did in 2024, up to 81 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 370 | $41,865 |
| New patient visit (30+ min) | 204 | $22,957 |
| 1ST HOSP IP/OBS HIGH 75 | 42 | $5,640 |
| 2024 | 616 | 3 | 81 | $70,462 |
| 2023 | 824 | 4 | 106 | $75,995 |
| 2022 | 674 | 8 | 32 | $31,781 |
| 2021 | 45 | 2 | 31 | $2,161 |
| 2020 | 33 | 1 | 16 | $2,235 |
| 2019 | 45 | 3 | 19 | $2,590 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 527 | $50,881 |
| New patient visit (30+ min) | 170 | $18,037 |
| Return visit (30+ min) | 114 | $6,300 |
| Long return visit (40+ min) | 13 | $776 |
2022
| Return visit (30+ min) | 280 | $13,506 |
| Short return visit (20+ min) | 287 | $13,444 |
| New patient visit (45+ min) | 20 | $1,731 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 15 | $1,600 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 24 | $562 |
| Long return visit (40+ min) | 13 | $504 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 21 | $434 |
| Discharge medications reconciled with the current medication list in outpatient medical record (COA) (GER) | 14 | $0 |
2021
| New patient visit (45+ min) | 32 | $2,028 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 13 | $133 |
2020
| Return visit (30+ min) | 33 | $2,235 |
2019
| New patient visit (45+ min) | 19 | $2,347 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $130 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $113 |
Drugs they prescribed that Part D paid
$8,896
Pharmacies billed $8,896 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
275 generic and fewer than 11 brand-name prescriptions · $8,896 in drug cost · 89 antibiotic prescriptions to 84 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 23 | $300 | $13 |
| Albuterol Sulfate Hfa | 11 | $226 | $21 |
| Azithromycin | 32 | $117 | $4 |
| Atorvastatin | 13 | $115 | $9 |
| Ibuprofen | 16 | $88 | $5 |
See all 6 drugs
| Amoxicillin-Clavulanate Potass | 23 | $300 | $13 |
| Albuterol Sulfate Hfa | 11 | $226 | $21 |
| Azithromycin | 32 | $117 | $4 |
| Atorvastatin | 13 | $115 | $9 |
| Ibuprofen | 16 | $88 | $5 |
| Prednisone | 16 | $16 | $1 |
Year by year
| 2024 | 304 | 201 | None | None | $8,896 |
| 2023 | 4,076 | 492 | 1% (59) | 13% | $366,602 |
| 2022 | 4,754 | 449 | 2% (107) | 13% | $509,165 |
| 2021 | 1,845 | 329 | 4% (74) | 14% | $160,955 |
| 2020 | 688 | 149 | 4% (24) | None | $35,491 |
| 2019 | 136 | 42 | None | None | $10,036 |
| 2018 | 197 | 53 | None | None | $14,267 |
| 2017 | 240 | 55 | None | 12% | $9,970 |
| 2016 | 55 | 17 | None | 22% | $3,673 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 83 drugs
| Ozempic | 29 | $32,918 | $1,135 |
| Lantus | 25 | $28,498 | $1,140 |
| Januvia | 15 | $22,315 | $1,488 |
| Humalog | 14 | $18,795 | $1,342 |
| Eliquis | 24 | $17,404 | $725 |
| Jardiance | 24 | $16,395 | $683 |
| Myrbetriq | 15 | $10,146 | $676 |
| Lantus Solostar | 21 | $8,402 | $400 |
| Linzess | 12 | $7,647 | $637 |
| Gabapentin | 187 | $3,420 | $18 |
| Atorvastatin | 290 | $3,307 | $11 |
| Albuterol Sulfate Hfa | 140 | $2,895 | $21 |
| Levothyroxine | 172 | $2,670 | $16 |
| Metformin | 169 | $1,711 | $10 |
| Losartan | 89 | $1,459 | $16 |
| Trazodone | 109 | $1,404 | $13 |
| Valacyclovir | 14 | $1,352 | $97 |
| Donepezil | 17 | $1,266 | $74 |
| Insulin | 23 | $1,227 | $53 |
| Valsartan-Hydrochlorothiazide | 12 | $1,194 | $100 |
| Lisinopril | 139 | $1,125 | $8 |
| Hydroxyzine | 24 | $1,107 | $46 |
| Omeprazole | 52 | $938 | $18 |
| Simvastatin | 74 | $883 | $12 |
| Pantoprazole | 63 | $871 | $14 |
| Alendronate | 71 | $867 | $12 |
| Amlodipine Besylate | 121 | $836 | $7 |
| Rosuvastatin | 46 | $829 | $18 |
| Buspirone | 38 | $818 | $22 |
| Potassium Chloride | 18 | $792 | $44 |
| Glipizide | 81 | $789 | $10 |
| Hydralazine | 31 | $695 | $22 |
| Cyclobenzaprine | 46 | $675 | $15 |
| Metoprolol | 74 | $625 | $8 |
| Tamsulosin | 29 | $624 | $22 |
| Fluticasone Propionate | 31 | $596 | $19 |
| Amitriptyline | 11 | $579 | $53 |
| Metoprolol | 46 | $570 | $12 |
| Duloxetine | 35 | $559 | $16 |
| Pregabalin | 12 | $550 | $46 |
| Glipizide Er | 24 | $541 | $23 |
| Amoxicillin-Clavulanate Potass | 56 | $518 | $9 |
| Isosorbide Mononitrate Er | 19 | $484 | $25 |
| Ibuprofen | 32 | $471 | $15 |
| Nitrofurantoin Mono-Macro | 29 | $461 | $16 |
| Pioglitazone | 16 | $414 | $26 |
| Clopidogrel | 23 | $413 | $18 |
| Montelukast | 28 | $391 | $14 |
| Hydrocodone-Acetaminophen | 14 | $390 | $28 |
| Furosemide | 53 | $389 | $7 |
| Triamterene-Hydrochlorothiazid | 16 | $377 | $24 |
| Escitalopram | 49 | $349 | $7 |
| Oxybutynin Chloride | 14 | $342 | $24 |
| Famotidine | 19 | $332 | $17 |
| Ondansetron | 17 | $318 | $19 |
| Hydrochlorothiazide | 61 | $309 | $5 |
| Oxycodone | 28 | $302 | $11 |
| Fluoxetine | 24 | $293 | $12 |
| Ropinirole | 17 | $278 | $16 |
| Memantine | 18 | $251 | $14 |
| Doxycycline Monohydrate | 15 | $238 | $16 |
| Tizanidine | 21 | $234 | $11 |
| Allopurinol | 12 | $224 | $19 |
| Pravastatin | 11 | $215 | $20 |
| Losartan-Hydrochlorothiazide | 11 | $213 | $19 |
| Methocarbamol | 19 | $213 | $11 |
| Lisinopril-Hydrochlorothiazide | 15 | $211 | $14 |
| Ezetimibe | 11 | $211 | $19 |
| Paxlovid (Eua) | 19 | $206 | $11 |
| Carvedilol | 25 | $193 | $8 |
| Chlorthalidone | 14 | $182 | $13 |
| Sulfamethoxazole-Trimethoprim | 33 | $173 | $5 |
| Bupropion Hcl Sr | 12 | $172 | $14 |
| Oxycodone-Acetaminophen | 11 | $172 | $16 |
| Azithromycin | 43 | $167 | $4 |
| Olanzapine | 11 | $161 | $15 |
| Meclizine | 12 | $158 | $13 |
| Atenolol | 18 | $140 | $8 |
| Benazepril | 11 | $132 | $12 |
| Triamcinolone Acetonide | 11 | $132 | $12 |
| Spironolactone | 12 | $129 | $11 |
| Citalopram Hbr | 20 | $100 | $5 |
| Prednisone | 24 | $34 | $1 |
2022: 95 drugs
| Lantus | 37 | $40,808 | $1,103 |
| Humalog | 35 | $36,212 | $1,035 |
| Eliquis | 43 | $26,041 | $606 |
| Jardiance | 26 | $18,255 | $702 |
| Januvia | 18 | $17,031 | $946 |
| Xarelto | 18 | $12,733 | $707 |
| Lantus Solostar | 16 | $11,643 | $728 |
| Albuterol Sulfate Hfa | 143 | $6,332 | $44 |
| Flovent Diskus | 13 | $5,101 | $392 |
| Gabapentin | 196 | $4,781 | $24 |
| Flovent Hfa | 12 | $4,010 | $334 |
| Levothyroxine | 181 | $3,948 | $22 |
| Atorvastatin | 349 | $3,847 | $11 |
| Cyclobenzaprine | 80 | $3,215 | $40 |
| Trazodone | 112 | $2,083 | $19 |
| Montelukast | 30 | $1,755 | $58 |
| Ibuprofen | 48 | $1,546 | $32 |
| Donepezil | 32 | $1,534 | $48 |
| Nifedipine Er | 17 | $1,298 | $76 |
| Hydroxyzine | 32 | $1,276 | $40 |
| Pantoprazole | 68 | $1,275 | $19 |
| Amlodipine Besylate | 150 | $1,255 | $8 |
| Omeprazole | 61 | $1,246 | $20 |
| Metformin | 219 | $1,238 | $6 |
| Tamsulosin | 57 | $1,206 | $21 |
| Alendronate | 62 | $1,182 | $19 |
| Nano 2nd Gen Pen Needle | 14 | $1,179 | $84 |
| Insulin | 19 | $1,092 | $57 |
| Amoxicillin-Clavulanate Potass | 62 | $1,011 | $16 |
| Ondansetron | 26 | $1,006 | $39 |
| Metoprolol | 94 | $1,003 | $11 |
| Oxycodone | 44 | $964 | $22 |
| Clopidogrel | 39 | $954 | $24 |
| Losartan | 102 | $942 | $9 |
| Amitriptyline | 19 | $936 | $49 |
| Lisinopril | 183 | $930 | $5 |
| Fluticasone Propionate | 35 | $924 | $26 |
| Buspirone | 20 | $910 | $46 |
| Rosuvastatin | 37 | $869 | $23 |
| Glipizide | 100 | $834 | $8 |
| Metoprolol | 46 | $798 | $17 |
| Venlafaxine Hcl Er | 25 | $792 | $32 |
| Tizanidine | 29 | $740 | $26 |
| Simvastatin | 101 | $737 | $7 |
| Hydralazine | 25 | $674 | $27 |
| Pregabalin | 25 | $668 | $27 |
| Bupropion | 21 | $635 | $30 |
| Duloxetine | 25 | $604 | $24 |
| Nyamyc | 11 | $581 | $53 |
| Potassium Chloride | 16 | $578 | $36 |
| Isosorbide Mononitrate Er | 18 | $539 | $30 |
| Bumetanide | 12 | $515 | $43 |
| Famotidine | 24 | $507 | $21 |
| Escitalopram | 52 | $506 | $10 |
| Hydrochlorothiazide | 69 | $483 | $7 |
| Fenofibrate | 12 | $478 | $40 |
| Methocarbamol | 30 | $472 | $16 |
| Acyclovir | 18 | $467 | $26 |
| Meclizine | 21 | $463 | $22 |
| Doxycycline Monohydrate | 20 | $453 | $23 |
| Hydrocodone-Acetaminophen | 23 | $446 | $19 |
| Finasteride | 15 | $436 | $29 |
| Estradiol | 16 | $426 | $27 |
| Furosemide | 52 | $404 | $8 |
| Fluoxetine | 14 | $401 | $29 |
| Sertraline | 23 | $362 | $16 |
| Triamterene-Hydrochlorothiazid | 26 | $355 | $14 |
| Oxybutynin Chloride | 16 | $330 | $21 |
| Nitrofurantoin Mono-Macro | 16 | $326 | $20 |
| Carisoprodol | 13 | $318 | $24 |
| Chlorthalidone | 25 | $300 | $12 |
| Carvedilol | 27 | $286 | $11 |
| Sulfamethoxazole-Trimethoprim | 41 | $281 | $7 |
| Ropinirole | 13 | $268 | $21 |
| Pioglitazone | 15 | $263 | $18 |
| Zolpidem | 24 | $255 | $11 |
| Bupropion Hcl Sr | 13 | $252 | $19 |
| Sumatriptan | 16 | $250 | $16 |
| Oxycodone-Acetaminophen | 16 | $240 | $15 |
| Glipizide Er | 27 | $234 | $9 |
| Allopurinol | 17 | $217 | $13 |
| Terbinafine | 23 | $183 | $8 |
| Triamcinolone Acetonide | 15 | $173 | $12 |
| Atenolol | 19 | $156 | $8 |
| Trueplus Insulin | 11 | $133 | $12 |
| Paxlovid (Eua) | 12 | $126 | $11 |
| Meloxicam | 13 | $119 | $9 |
| Lisinopril-Hydrochlorothiazide | 19 | $108 | $6 |
| Tramadol | 21 | $105 | $5 |
| Benazepril | 12 | $105 | $9 |
| Citalopram Hbr | 13 | $86 | $7 |
| Alprazolam | 12 | $83 | $7 |
| Clonazepam | 13 | $65 | $5 |
| Euthyrox | 12 | $52 | $4 |
| Prednisone | 12 | $24 | $2 |
2021: 42 drugs
| Jardiance | 30 | $18,509 | $617 |
| Novolog Mix 70-30 Flexpen | 18 | $16,198 | $900 |
| Lantus | 20 | $13,494 | $675 |
| Lantus Solostar | 12 | $11,044 | $920 |
| Albuterol Sulfate Hfa | 45 | $1,817 | $40 |
| Levothyroxine | 85 | $1,684 | $20 |
| Gabapentin | 57 | $1,605 | $28 |
| Cyclobenzaprine | 37 | $1,058 | $29 |
| Atorvastatin | 95 | $1,015 | $11 |
| Omeprazole | 34 | $962 | $28 |
| Diclofenac | 12 | $834 | $70 |
| Ropinirole | 24 | $800 | $33 |
| Trazodone | 37 | $794 | $21 |
| Baclofen | 16 | $718 | $45 |
| Duloxetine | 31 | $709 | $23 |
| Pantoprazole | 24 | $620 | $26 |
| Diclofenac | 12 | $544 | $45 |
| Amlodipine Besylate | 92 | $532 | $6 |
| Lisinopril | 81 | $490 | $6 |
| Metformin | 57 | $479 | $8 |
| Nitrofurantoin Mono-Macro | 15 | $467 | $31 |
| Losartan | 58 | $455 | $8 |
| Hydroxyzine | 14 | $368 | $26 |
| Tamsulosin | 24 | $358 | $15 |
| Zolpidem | 35 | $321 | $9 |
| Ibuprofen | 14 | $319 | $23 |
| Oxycodone | 16 | $300 | $19 |
| Clopidogrel | 17 | $267 | $16 |
| Carvedilol | 20 | $262 | $13 |
| Sertraline | 19 | $256 | $13 |
| Metoprolol | 21 | $230 | $11 |
| Amoxicillin-Clavulanate Potass | 27 | $222 | $8 |
| Warfarin | 15 | $221 | $15 |
| Escitalopram | 20 | $185 | $9 |
| Bupropion Hcl Sr | 11 | $181 | $16 |
| Tramadol | 35 | $177 | $5 |
| Simvastatin | 19 | $176 | $9 |
| Furosemide | 21 | $163 | $8 |
| Glipizide | 16 | $149 | $9 |
| Hydrochlorothiazide | 26 | $126 | $5 |
| Sulfamethoxazole-Trimethoprim | 18 | $102 | $6 |
| Atenolol | 13 | $89 | $7 |
2020: 14 drugs
| Gabapentin | 38 | $1,053 | $28 |
| Albuterol Sulfate Hfa | 13 | $788 | $61 |
| Metoprolol | 17 | $422 | $25 |
| Levothyroxine | 18 | $418 | $23 |
| Losartan | 32 | $336 | $11 |
| Omeprazole | 17 | $284 | $17 |
| Amlodipine Besylate | 33 | $266 | $8 |
| Atorvastatin | 32 | $250 | $8 |
| Pantoprazole | 11 | $191 | $17 |
| Duloxetine | 13 | $159 | $12 |
| Oxycodone | 12 | $159 | $13 |
| Hydrochlorothiazide | 27 | $135 | $5 |
| Trazodone | 14 | $118 | $8 |
| Lisinopril | 26 | $115 | $4 |
2019: 1 drug
| Amlodipine Besylate | 15 | $68 | $5 |
2018: 5 drugs
| Pantoprazole | 18 | $145 | $8 |
| Hydrochlorothiazide | 17 | $109 | $6 |
| Metoprolol | 13 | $92 | $7 |
| Amlodipine Besylate | 19 | $83 | $4 |
| Lisinopril | 12 | $70 | $6 |
2017: 3 drugs
| Atorvastatin | 15 | $169 | $11 |
| Amlodipine Besylate | 26 | $133 | $5 |
| Hydrochlorothiazide | 13 | $27 | $2 |
Money from drug and device companies
$28 in 2019
A payment is not proof that care is biased.
| AbbVie | Humira | $15 | 1 payment
|
| Novo Nordisk | None | $13 | 1 payment
|
See all 2 published payments
| Novo Nordisk | Meals · 2019-05-13 | None | $13 |
| AbbVie | Meals · 2019-02-20 | Humira | $15 |
Professional record
- NPI
- 1740635721
- Licence
- AZ 008117
- Trained
- Midwestern University, Chicago College of Osteopathic Med, 2016 · 10 years ago
- Group
- Nextcare Arizona I Jv LLC · Circle the City · Vituity - Arizona Hospitalists PC · Banner-University Medical Group
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2016-04-27
- NPI last updated
- 2026-02-16
- NPI record certified
- 2026-02-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 8041 N Black Canyon Hwy, Phoenix, AZ, 85021